Shoulder INNOVATIONS, Inc. (SI) intrinsic value & 10-year financials

Shoulder INNOVATIONS, Inc. (SI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue grew 49.6% a year to $47.3M, with an average return on invested capital of -15.9%.

Graham intrinsic value
—
Share price (Oct 16, 2026)
$18.09
Market cap
$156.9M
Revenue (FY2025)
$47.3M
Revenue growth (3-yr CAGR)
49.6%
ROIC (10-yr avg)
-15.9%
Free cash flow (FY2025)
-$36.0M

SI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $47.3M -$40.4M -$4.65 -$36.0M -55.6% -63.7%
FY2024 $31.6M -$15.6M -$1.81 -$18.2M -46.3% 31.7%
FY2023 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

SHOULDER INNOVATIONS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

SHOULDER INNOVATIONS, INC. has historically struggled to out-earn its cost of capital, averaging just -16.0% ROIC.

SHOULDER INNOVATIONS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, SHOULDER INNOVATIONS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-154.45 per share.

SI stock: frequently asked questions

What is the intrinsic value of Shoulder INNOVATIONS, Inc. (SI) stock?

Graham's formula only works with positive earnings. Shoulder INNOVATIONS, Inc. reported diluted EPS of -$4.65 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Shoulder INNOVATIONS, Inc. generate free cash flow?

Shoulder INNOVATIONS, Inc. generated -$36.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 2 reported years.

What is SI's return on invested capital?

Average ROIC over the last 3 fiscal years was -15.9%, and average return on equity was -30.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SI data come from?

From Shoulder INNOVATIONS, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks